In 1995, guidance about new drugs for multiple sclerosis and clinical advice from the Scottish Medical Advisory Committee was issued to all health boards and this guidance continues to apply.The Health Technology Board for Scotland is at present carrying out an assessment of Beta Interferon and Copaxone in the treatment of multiple sclerosis.